Product SpecificationHost | Human | Antigen | PD-1 | Synonyms | Programmed cell death protein 1, Protein PD-1, hPD-1, CD279, PDCD1 | Accession | Q15116 | Clone Number | S-SC016 | Antibody Type | Recombinant mAb | Isotype | IgG4,k | Application | Blocking of PD-1/PD-L signaling Functional assays | Purification | Protein A | Concentration | 2 mg/ml | Endotoxin | <1EU/mg | Conjugation | Unconjugated | Physical Appearance | Liquid | Storage Buffer | PBS pH7.4, containing no preservative | Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilutionapplication | dilution | species | ELISA | 0.305-5000 ng/ml | |
BackgroundNivolumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells. bio-equip.cn
AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
|